| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017009925 |
| P356 | DOI | 10.1038/CLPT.1990.69 |
| P698 | PubMed publication ID | 2328562 |
| P5875 | ResearchGate publication ID | 20826649 |
| P2093 | author name string | Stewart CF | |
| Arkin CR | |||
| Evans WE | |||
| Fleming RA | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| methotrexate | Q422232 | ||
| naproxen | Q1215575 | ||
| P304 | page(s) | 540-546 | |
| P577 | publication date | 1990-04-01 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis | |
| P478 | volume | 47 |
| Q36825493 | A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM. |
| Q40886062 | Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance |
| Q44790474 | Aspirin alters methotrexate disposition in rheumatoid arthritis patients |
| Q37290781 | Clinical pharmacokinetics of drugs used in juvenile arthritis |
| Q41177632 | Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis |
| Q41440092 | Clinical pharmacokinetics of naproxen |
| Q46711323 | Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis |
| Q40799829 | Comparing the strengths and weaknesses of observational and experimental studies using a postmarketing surveillance study as a protypic example. |
| Q45915302 | Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment |
| Q45038809 | Lumiracoxib does not affect methotrexate pharmacokinetics in rheumatoid arthritis patients |
| Q37433305 | Measuring transaminases in patients with rheumatoid arthritis on weekly methotrexate: does timing of blood testing matter? |
| Q34552688 | Methotrexate and nonsteroidal antiinflammatory drug interactions |
| Q34346674 | Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis |
| Q72281579 | Methotrexate in juvenile rheumatoid arthritis. Evidence of age dependent pharmacokinetics |
| Q41757845 | Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity |
| Q41635852 | Pharmacology and pharmacokinetics of methotrexate in rheumatic disease. Practical issues in treatment and design |
| Q44140105 | Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate |
| Q35825137 | Population pharmacokinetic analysis of meloxicam in rheumatoid arthritis patients |
| Q40925900 | Slow-acting antirheumatic drugs. Drug interactions of clinical significance |
| Q37455123 | Symmetric dimethyl arginine and N-acetyl-β-D-glucosaminidase lysozimuria of proximal renal tubules as a target for nephrotoxicity in patients with rheumatoid arthritis treated with disease modifying antirheumatic drugs |
| Q34561120 | The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis |
| Q35803314 | The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis |
| Q33503295 | Thrombocytopenia after a single test dose of methotrexate |
| Q33496750 | Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate |
| Q71502428 | Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate |
| Q71912979 | Use of methotrexate in older patients. A risk-benefit assessment |
| Q24235194 | Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthriti |
Search more.